Industry Strength Score
21/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
OMNIAB INC (OABI) Stock Price & Overview
NASDAQ:OABI • US68218J1034
Current stock price
1.39 USD
+0.03 (+2.21%)
At close:
1.45 USD
+0.06 (+4.32%)
After Hours:
The current stock price of OABI is 1.39 USD. Today OABI is up by 2.21%. In the past month the price decreased by -10.9%. In the past year, price decreased by -20.57%.
OABI Key Statistics
52-Week Range1.22 - 2.295
Current OABI stock price positioned within its 52-week range.
1-Month Range1.35 - 1.65
Current OABI stock price positioned within its 1-month range.
- Market Cap
- 201.244M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.57
- Dividend Yield
- N/A
OABI Stock Performance
Today
+2.21%
1 Week
-10.90%
1 Month
-10.90%
3 Months
-23.63%
Longer-term
6 Months -10.32%
1 Year -20.57%
2 Years -68.69%
3 Years -60.06%
5 Years N/A
10 Years N/A
OABI Stock Chart
OABI Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to OABI. When comparing the yearly performance of all stocks, OABI is a bad performer in the overall market: 86.66% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
OABI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to OABI. While OABI has a great health rating, there are worries on its profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
OABI Earnings
On March 4, 2026 OABI reported an EPS of -0.11 and a revenue of 8.38M. The company missed EPS expectations (-21.76% surprise) and missed revenue expectations (-8.79% surprise).
Next Earnings DateMay 7, 2026
Last Earnings DateMar 4, 2026
PeriodQ4 / 2025
EPS Reported-$0.11
Revenue Reported8.376M
EPS Surprise -21.76%
Revenue Surprise -8.79%
OABI Forecast & Estimates
13 analysts have analysed OABI and the average price target is 7.48 USD. This implies a price increase of 438.13% is expected in the next year compared to the current price of 1.39.
For the next year, analysts expect an EPS growth of 31.49% and a revenue growth 44.88% for OABI
Analysts
Analysts84.62
Price Target7.48 (438.13%)
EPS Next Y31.49%
Revenue Next Year44.88%
OABI Index Membership
OABI is currently included in the following stock indexes tracked on ChartMill.
OABI Financial Highlights
Over the last trailing twelve months OABI reported a non-GAAP Earnings per Share(EPS) of -0.57. The EPS increased by 5% compared to the year before.
Income Statements
Revenue(TTM)18.67M
Net Income(TTM)-64.78M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -21.53% | ||
| ROE | -24.26% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%8.33%
Sales Q2Q%-22.47%
EPS 1Y (TTM)5%
Revenue 1Y (TTM)-29.27%
OABI Ownership
Ownership
Inst Owners40.56%
Shares144.78M
Float106.90M
Ins Owners6.73%
Short Float %5.11%
Short Ratio13.4
OABI Industry Overview
OABI operates in the Life Sciences Tools & Services sub-industry within the Health Care sector. This group contains 51 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
54/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
40%
Outperformed 40% of sub-industries
3 Month Rank
8%
Outperformed 8% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries
Industry Fundamentals & Breadth
- Members
- 51
- New Highs
- 0%
- New Lows
- 5.9%
- Average ROE
- 14.9%
- Average Profit Margin
- 15.8%
- Average Operating Margin
- 18.7%
- Average P/E
- 33.4
- Average Fwd P/E
- 28.9
- Average Debt/Equity
- 0.8
OABI Competitors/Peers
The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 17.68 | 173.272B | ||
| DHR | DANAHER CORP | 19.44 | 126.537B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 135.66 | 41.885B | ||
| A | AGILENT TECHNOLOGIES INC | 17.2 | 31.453B | ||
| WAT | WATERS CORP | 21.27 | 28.678B | ||
| IQV | IQVIA HOLDINGS INC | 12.35 | 26.299B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 27.18 | 25.113B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 33.11 | 21.29B | ||
| ILMN | ILLUMINA INC | 24.22 | 18.285B | ||
| MEDP | MEDPACE HOLDINGS INC | 21.63 | 11.812B | ||
| RVTY | REVVITY INC | 15.74 | 9.197B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 8.974B | ||
| TECH | BIO-TECHNE CORP | 24.9 | 8.128B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About OABI
Company Profile
OmniAb, Inc. operates as a drug discovery company. The company is headquartered in Emeryville, California and currently employs 89 full-time employees. The company went IPO on 2020-10-09. Its technology platform creates and screens diverse antibody repertoires and is designed to identify optimal antibodies and other target-binding proteins for its partners’ drug development efforts. Central to the OmniAb platform, Biological Intelligence, powers the immune systems of its engineered transgenic animals to create optimized antibody candidates for human therapeutics. Its proprietary transgenic animals, including OmniRat, OmniChicken and OmniMouse are genetically modified to generate antibodies with human sequences to streamline the development of human therapeutic candidates. OmniFlic and OmniClic are fixed or common light-chain rats and chickens, designed to facilitate the discovery of bispecific antibodies. OmniTaur provides cow-inspired antibodies with unique structural characteristics for challenging targets.
Company Info
IPO: 2020-10-09
OMNIAB INC
5980 Horton Street, Suite 600
Emeryville CALIFORNIA US
Employees: 89
Phone: 15102507800
OMNIAB INC / OABI FAQ
What does OMNIAB INC do?
OmniAb, Inc. operates as a drug discovery company. The company is headquartered in Emeryville, California and currently employs 89 full-time employees. The company went IPO on 2020-10-09. Its technology platform creates and screens diverse antibody repertoires and is designed to identify optimal antibodies and other target-binding proteins for its partners’ drug development efforts. Central to the OmniAb platform, Biological Intelligence, powers the immune systems of its engineered transgenic animals to create optimized antibody candidates for human therapeutics. Its proprietary transgenic animals, including OmniRat, OmniChicken and OmniMouse are genetically modified to generate antibodies with human sequences to streamline the development of human therapeutic candidates. OmniFlic and OmniClic are fixed or common light-chain rats and chickens, designed to facilitate the discovery of bispecific antibodies. OmniTaur provides cow-inspired antibodies with unique structural characteristics for challenging targets.
What is the stock price of OMNIAB INC today?
The current stock price of OABI is 1.39 USD. The price increased by 2.21% in the last trading session.
What is the dividend status of OMNIAB INC?
OABI does not pay a dividend.
How is the ChartMill rating for OMNIAB INC?
OABI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What do analysts say about OMNIAB INC (OABI) stock?
13 analysts have analysed OABI and the average price target is 7.48 USD. This implies a price increase of 438.13% is expected in the next year compared to the current price of 1.39.
Can you provide the market cap for OMNIAB INC?
OMNIAB INC (OABI) has a market capitalization of 201.24M USD. This makes OABI a Micro Cap stock.